Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

NCT04917042 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Nerve Sheath Tumor

Interventions

DRUG: Tazemetostat

Sponsor

University of Florida

Collaborators

[object Object]